All In Biotech

Free tool

FAERS Monitor: Avita

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020404 or its brand name (Avita, Tretinoin). Reports on generic versions are filed under their own applications.

Reports

6,524

Serious

4,112

63% of reports

Hospitalization

1,416

Death reported

851

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use876
  • drug ineffective727
  • pain489
  • product use in unapproved indication483
  • vomiting450
  • paraesthesia372
  • abdominal pain upper368
  • rash361
  • nausea350
  • diarrhoea347
  • maternal exposure during pregnancy338
  • headache335
  • taste disorder332
  • drug intolerance327
  • gastrooesophageal reflux disease327

Reports by year received

View as table
YearReports
200437
200531
200624
200739
2008114
200972
201078
201189
2012153
2013100
2014147
2015223
2016342
2017343
2018460
2019350
2020374
2021426
2022510
2023568
2024674
2025809
2026561

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,047,635 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
taste disorderSignal33253.648.216,828
gastrooesophageal reflux diseaseSignal32713.111.83,656
maternal exposure during pregnancySignal33812.311.13,489
drug intoleranceSignal32710.99.82,949
paraesthesiaSignal3727.66.92,151
product use in unapproved indicationSignal4836.35.82,166
abdominal pain upperSignal3685.85.21,458
off label useSignal8763.23.01,401
vomitingSignal4503.12.8647
rashSignal3612.72.4383
painSignal4892.62.4480
drug ineffective7271.81.7264
diarrhoea3471.71.6110
headache3351.71.6104
nausea3501.41.346

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.